Is Lucid Diagnostics Inc. (LUCD) Stock Halal or Haram?
Lucid Diagnostics Inc. (LUCD) - Not Halal (Non-Compliant)
Lucid Diagnostics Inc. (LUCD) is classified as Not Halal (Non-Compliant) according to AAOIFI Shariah screening standards. This assessment is based on business activity screening and financial ratio analysis using the AAOIFI methodology.
Business Activity Screen
Sector
Healthcare
Industry
Medical Devices
Result
Pass
Reason
The sector "Healthcare" and industry "Medical Devices" are not in the excluded categories.
Financial Ratios
Debt Ratio
Value: 12.0% | Threshold: 30% | Result: Pass
Cash & Interest-bearing Securities Ratio
Value: 16.0% | Threshold: 30% | Result: Pass
Non-Permissible Income Ratio
Value: 8.2% | Threshold: 5% | Result: Fail
Dividend Purification
Purification percentage: 8.20%.Based on the company's financial statements, approximately 8.20% of dividend income comes from non-permissible sources; this is the share many investors donate to purify it. This is derived from identified interest income (8.20% of total income). Some scholars may differ on the exact calculation method.
About Lucid Diagnostics Inc.
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. The company's flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.
Frequently Asked Questions
Is Lucid Diagnostics Inc. (LUCD) stock halal to invest in?
According to AAOIFI Shariah screening standards, Lucid Diagnostics Inc. (LUCD) is currently classified as Not Halal (Non-Compliant). This is based on both business activity and financial ratio screening.
Does Lucid Diagnostics Inc. have any interest income?
Based on the company's financial statements, approximately 8.20% of dividend income comes from non-permissible sources; this is the share many investors donate to purify it. This is derived from identified interest income (8.20% of total income). Some scholars may differ on the exact calculation method.
Uses quarterly data
About Lucid Diagnostics Inc.
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. The company's flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.
United StatesNASDAQHealthcare
Screened using AAOIFI Standard No. 21 on October 30, 2026. Financial ratios compared against market capitalization. Different methodologies may produce different results. Learn how we screen.
Screened using AAOIFI Shariah Standard No. 21 (3 ratios). Debt and interest-bearing deposits must each be under 30% of market capitalization, and non-permissible income under 5% of total income. This screening is for educational purposes only and does not constitute a fatwa or religious ruling. Results are based on publicly available financial data and automated analysis. Users should consult qualified Islamic scholars and financial advisors for personal investment decisions. Financial data may be delayed or incomplete. Past compliance does not guarantee future status.
Verdict history
Free with an account.
No verdict changes recorded since first screened on Oct 23, 2026. We started recording changes on Oct 23, 2026.
Dates are when Mizaan recorded the change. Tracked and watched stocks are re-checked weekly; other stocks are re-screened on demand.
Get More on the Mizaan App
Live charts, market cap, financials, AI business analysis, portfolio tracking, and compliance alerts — all on your phone.
Frequently Asked Questions
According to AAOIFI Shariah screening standards, Lucid Diagnostics Inc. (LUCD) is currently classified as Not Halal (Non-Compliant). This is based on both business activity and financial ratio screening.
Identified interest income is 8.2% of Lucid Diagnostics Inc.'s total income. AAOIFI standards require non-permissible income to be below 5%.
LUCD is screened using AAOIFI Standard No. 21, which involves two checks: business activity screening (ensuring the company's core business is permissible in Islam) and financial ratio screening (checking debt, interest income, and cash ratios against defined thresholds). AAOIFI is the most widely recognized standard for Islamic finance.
Lucid Diagnostics Inc.'s compliance status is reviewed whenever new financial data becomes available, typically after quarterly or annual earnings reports. Market cap changes can also affect financial ratio screening results. Mizaan refreshes screening data periodically to reflect the latest filings.
Watch LUCD free with a Mizaan account. Watched stocks are re-checked weekly, and any verdict change is dated in the verdict history on this page. Premium members also get an alert when it changes.
Approximately 8.20% of dividend income from Lucid Diagnostics Inc. comes from non-permissible sources such as interest income. Many investors purify that share by donating it to charity; scholars differ on the details, so check with one you trust.
Yes, Zakat is generally due on stock holdings. The calculation depends on your school of thought (madhab) and whether you hold shares for trading or long-term investment. Use Mizaan's Zakat calculator to compute your obligation based on your specific madhab and holding intent.
Identified interest income is 8.2% of Lucid Diagnostics Inc.'s total income. AAOIFI standards require non-permissible income to be below 5%.
What guidelines are used to determine if LUCD stock is Shariah-compliant?
LUCD is screened using AAOIFI Standard No. 21, which involves two checks: business activity screening (ensuring the company's core business is permissible in Islam) and financial ratio screening (checking debt, interest income, and cash ratios against defined thresholds). AAOIFI is the most widely recognized standard for Islamic finance.
How often is Lucid Diagnostics Inc. stock reviewed for Shariah compliance?
Lucid Diagnostics Inc.'s compliance status is reviewed whenever new financial data becomes available, typically after quarterly or annual earnings reports. Market cap changes can also affect financial ratio screening results. Mizaan refreshes screening data periodically to reflect the latest filings.
How can I stay updated on Lucid Diagnostics Inc.'s compliance status?
Watch LUCD free with a Mizaan account. Watched stocks are re-checked weekly, and any verdict change is dated in the verdict history on this page. Premium members also get an alert when it changes.
Are dividends from Lucid Diagnostics Inc. stock considered halal?
Approximately 8.20% of dividend income from Lucid Diagnostics Inc. comes from non-permissible sources such as interest income. Many investors purify that share by donating it to charity; scholars differ on the details, so check with one you trust.
Do I need to pay Zakat on my Lucid Diagnostics Inc. shares?
Yes, Zakat is generally due on stock holdings. The calculation depends on your school of thought (madhab) and whether you hold shares for trading or long-term investment. Use Mizaan's Zakat calculator to compute your obligation based on your specific madhab and holding intent.
